Novavax's market cap is currently $1.36B. The company's EPS TTM is $0.62; its P/E ratio is 3.76; Novavax is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
